Park Edge Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1965659 Cleveland, OH

Position in JNJ

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$4,211,838

+$1,590,953 QoQ

Shares Held

16,584

+54.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.50%

of 13F equity value

Holder Rank

#1,739

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Park Edge Advisors, LLC holds $9,575,115 across 7 Drug Manufacturers - General names. JNJ ranks #1 (44.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	16,584	$4,211,838
2	GILD	Gilead Sciences, Inc.	10,590	$1,337,940
3	LLY	ELI LILLY & Co	1,061	$1,272,595
4	ABBV	AbbVie Inc.	3,457	$869,919
5	BMY	Bristol Myers Squibb Co	14,381	$828,633
6	MRK	Merck & Co., Inc.	4,378	$562,573
7	PFE	Pfizer Inc	20,416	$491,617

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,211,838	16,584	+54.7%	Shares	Sole	2026-07-13
2026-03-31	$2,620,885	10,722	-0.1%	Shares	Sole	2026-04-20
2025-12-31	$2,222,229	10,738	0.0%	Shares	Sole	2026-01-16
2025-09-30	$1,991,039	10,738	+0.1%	Shares	Sole	2025-10-09
2025-06-30	$1,639,313	10,732	-0.0%	Shares	Sole	2025-07-07
2025-03-31	$1,780,126	10,734	-0.2%	Shares	Sole	2025-04-10
2024-12-31	$1,555,532	10,756	0.0%	Shares	Sole	2025-01-21
2024-09-30	$1,743,117	10,756	-3.6%	Shares	Sole	2024-10-24
2024-06-30	$1,630,560	11,156	-1.4%	Shares	Sole	2024-07-26
2024-03-31	$1,789,603	11,313	0.0%	Shares	Sole	2024-04-19
2023-12-31	$1,773,199	11,313	-19.2%	Shares	Sole	2024-01-12
2023-09-30	$2,180,967	14,003	+9.0%	Shares	Sole	2023-10-11
2023-06-30	$2,125,938	12,844	+0.0%	Shares	Sole	2023-07-13
2023-03-31	$1,990,045	12,839	-3.4%	Shares	Sole	2023-04-18
2022-12-31	$2,347,855	13,291	—	Shares	Sole	2023-04-14
No filing history on record for this holder in this stock.